Individualized treatment of diabetes mellitus in older adults
Author:
Open Access
- 7 October 2024
- journal article
- review article
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 24 (12) , 1257-1268
Abstract
The population of older adults with diabetes mellitus is growing but heterogeneous. Because geriatric syndromes, comorbidity or multimorbidity, the complexity of glucose dynamics, and socioeconomic conditions are associated with the risk of severe hypoglycemia and mortality, these factors should be considered in individualized diabetes treatment. Because cognitive impairment and frailty have similar etiologies and risk factors, a common strategy can be implemented to address them through optimal glycemic control, management of vascular risk factors, diet, exercise, social participation, and support. To prevent frailty or sarcopenia, optimal energy intake, adequate protein and vitamin intake, and resistance or multi‐component exercise are recommended. For hypoglycemic drug therapy, it is important to reduce hypoglycemia, to use sodium glucose cotransporter‐2 (SGLT2) inhibitors and glucagon‐like peptide‐1 (GLP‐1) receptor agonists, taking into account the benefits for cardiovascular disease and the risk of adverse effects, and to simplify treatment to address poor adherence. Glycemic control goals for older adults with diabetes should be set according to three categories, based on cognitive function and activities of daily living, using the Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items. This categorization can be used to determine treatment strategies for diabetes when combined with the Comprehensive Geriatric Assessment (CGA). Based on the CGA, frailty prevention, treatment simplification, and social participation or services should be implemented for patients in Category II and above. Measures against hypoglycemia and for the prevention of cardiovascular disease and chronic kidney disease should also be promoted. Treatment based on categorization and CGA by multidisciplinary professionals would be an individualized treatment for older adults with diabetes. Geriatr Gerontol Int 2024; 24: 1257–1268.Keywords
This publication has 96 references indexed in Scilit:
- Food Insecurity and Hypoglycemia among Older Patients with Type 2 Diabetes Treated with Insulin or Sulfonylureas: The Diabetes & Aging StudyJournal of General Internal Medicine, 2024
- Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysisCalcified Tissue International, 2020
- Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitusJournal of Cachexia, Sarcopenia and Muscle, 2019
- Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)Diabetologia, 2017
- Simplification of Insulin Regimen in Older Adults and Risk of HypoglycemiaJAMA Internal Medicine, 2016
- Risk of severe hypoglycemia in sulfonylurea‐treated patients from diabetes centers in Germany/Austria: How big is the problem? Which patients are at risk?Diabetes/Metabolism Research and Reviews, 2015
- Energy and protein intakes and their association with a decline in functional capacity among diabetic older adults from the NuAge cohortEuropean Journal of Nutrition, 2015
- National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and HospitalizationsJAMA Internal Medicine, 2014
- The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta‐analysisDiabetes/Metabolism Research and Reviews, 2014
- Association Between Hypoglycemia and Dementia in a Biracial Cohort of Older Adults With Diabetes MellitusJAMA Internal Medicine, 2013